Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis

Arthritis Research and Therapy

Volumn 16, Issue 2, 2014, Pages

  Van Steenbergen, Hanna W ^a   van Nies, Jessica A B ^a   Huizinga, Tom W J ^a   Reijnierse, Monique ^a   van der Helm van Mil, Annette H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; AUTOANTIBODY; AUTOANTIGEN;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; BONE MARROW EDEMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOOT; HAND; HUMAN; MAJOR CLINICAL STUDY; MALE; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; RHEUMATOID ARTHRITIS; RISK FACTOR; SYNOVITIS; BLOOD; DISEASE COURSE; EARLY DIAGNOSIS; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PATHOLOGY;

ADULT; ARTHRALGIA; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; FOOT; HAND; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; MIDDLE AGED; RISK FACTORS; SYNOVITIS;

EID: 84900463000     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4536     Document Type: Article

References (20)

1. van der Linden MPM, le Cessie S, Raza K, van der Woude D, Knevel R, Huizinga TWJ, van der Helm-van Mil AHM. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 2010, 62:3537-3546. 10.1002/art.27692, 20722031.
2. Quinn MA, Conaghan PG, Emery P. The therapeutic approach of early intervention for rheumatoid arthritis: What is the evidence?. Rheumatology (Oxford) 2001, 40:1211-1220. 10.1093/rheumatology/40.11.1211, 11709604.
3. van Steenbergen HW, Huizinga TWJ, van der Helm-van Mil AHM. The preclinical phase of rheumatoid arthritis: What is acknowledged and what needs to be assessed?. Arthritis Rheum 2013, 65:2219-2232. 10.1002/art.38013, 23686440.
4. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386. 10.1002/art.20018, 14872479.
5. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749. 10.1002/art.11223, 14558078.
6. Karlson EW, Chibnik LB, Tworoger SS, Lee IM, Buring JE, Shadick NA, Manson JE, Constenbader KH. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 2009, 60:641-652. 10.1002/art.24350, 2715148, 19248103.
7. Deane KD, O'Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, Gilliland WR, Edison JD, Norris JM, Robinson WH, Holers VM. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 2010, 62:3161-3172. 10.1002/art.27638, 2980824, 20597112.
8. Gent YY, Voskuyl AE, Kloet RW, van Schaardenburg D, Hoekstra OS, Dijkmans BA, Lammertsma AA, van der Laken CJ. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. Arthritis Rheum 2012, 64:62-66. 10.1002/art.30655, 21898356.
9. van de Stadt LA, Bos WH, Meursinge Reynders M, Wieringa H, Turkstra F, van der Laken CJ, van Schaardenburg D. The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study. Arthritis Res Ther 2010, 12:R98. 10.1186/ar3028, 2911885, 20487531.
10. Krabben A, Stomp W, van der Heijde DM, van Nies JA, Bloem JL, Huizinga TW, Reijnierse M, van der Helm-van Mil AH. MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis. Ann Rheum Dis 2013, 72:1540-1544. 10.1136/annrheumdis-2012-202628, 23334211.
11. Fautrel B, Combe B, Rincheval N, Dougados M, . ESPOIR Scientific Committee: Level of agreement of the, ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data. Ann Rheum Dis 1987, 2012:386-389. ESPOIR Scientific.
12. Cader MZ, Filer A, Hazlehurst J, de Pablo P, Buckley CD, Raza K. Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort. Ann Rheum Dis 2011, 70:949-955. Published errata appear in Ann Rheum Dis 2011, 70:1349. Ann Rheum Dis 2012, 71:1592.
13. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003, 48:1814-1827. 10.1002/art.11162, 12847674.
14. Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D'Agostino MA, Forslind K, Grassi W, Haavardsholm EA, Haugeberg G, Jurik AG, Landewé RB, Naredo E, O'Connor PJ, Ostendorf B, Potocki K, Schmidt WA, Smolen JS, Sokolovic S, Watt I, Conaghan PG. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013, 72:804-814. 10.1136/annrheumdis-2012-203158, 23520036.
15. Østergaard M, Edmonds J, McQueen F, Peterfy C, Lassere M, Ejbjerg B, Bird P, Emery P, Genant H, Conaghan P. An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 2005, 64:i3-i7. 10.1136/ard.2004.031773, 1766828, 15647420.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
17. Tamai M, Kawakami A, Uetani M, Takao S, Tanaka F, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Kamachi M, Huang M, Origuchi T, Ida H, Aoyagi K, Eguchi K. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis 2006, 65:133-134. 10.1136/ard.2005.04138, 1797979, 16344500.
18. van der Helm-van Mil AHM, Verpoort KN, Breedveld FC, Toes REM, Huizinga TWJ. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005, 7:R949-R958. 10.1186/ar1767, 1257421, 16207336.
19. Tamai M, Kawakami A, Uetani M, Fukushima A, Arima K, Fujikawa K, Iwamoto N, Aramaki T, Kamachi M, Nakamura H, Ida H, Origuchi T, Aoyagi K, Eguchi K. Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis: comparison of the accuracy of plain MRI-based findings and gadolinium-diethylenetriamine pentaacetic acid-enhanced MRI-based findings. Mod Rheumatol 2012, 22:654-658. 10.3109/s10165-011-0575-8, 22203216.
20. Østergaard M, Conaghan PG, O'Connor P, Szkudlarek M, Klarlund M, Emery P, Peterfy C, Genant H, McQueen FM, Bird P, Lassere M, Ejbjerg B. Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection-Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?. J Rheumatol 2009, 36:1806-1810. 10.3899/jrheum.090350, 19671817.